Skip to content
Screener

Balchem BCPC Human Nutrition and Health — D&A

Other segment segments

Animal Nutrition and Health
$1.86M+5.6%
Specialty Products
$1.76M+1.7%

Similar metrics at other companies

Colgate-Palmolive logo
CLPet Nutrition — D&A
$35M+12.9%
Phibro Animal Health logo
PAHCMineral Nutrition — D&A
$548K+4.6%
USANA Health Sciences logo
USNACore Nutritional — D&A
$3.6M-1.3%
The Clorox Company logo
CLXHealth and Wellness — D&A
$35M+119%
CVS Health logo
CVSHealth Services — D&A
$251M-3.5%
Phibro Animal Health logo
PAHCAnimal Health — D&A
$11.13M-2.1%

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.75B+10.8%
Enterprise value$5.72B+10.7%
P/E36.4×0.0×
P/S5.4×+0.2×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: Balchem’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:33 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000009326-26-000018
Depreciation/AmortizationThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Human Nutrition and Health$8,647$7,303
Animal Nutrition and Health1,8591,761
Specialty Products1,7551,726
Other and Unallocated230224
Total$12,491$11,014

Item 1. Financial Statements (unaudited)

FAQ

What is Balchem's human nutrition and health — D&A?
Balchem (BCPC) reported human nutrition and health — D&A of $8.65M in Q1 2026.
How has Balchem's human nutrition and health — D&A changed year-over-year?
Balchem's human nutrition and health — D&A increased by 18.4% year-over-year, from $7.3M to $8.65M.
What is the long-term trend for Balchem's human nutrition and health — D&A?
Over 4 years (2021 to 2025), Balchem's human nutrition and health — D&A has grown at a 0.1% compound annual growth rate (CAGR), from $30.01M to $30.12M.
What does human nutrition and health — D&A mean?
Reflects the systematic allocation of the cost of tangible and intangible assets over their useful lives within the Human Nutrition and Health segment. This non-cash expense is essential for understanding the segment's capital maintenance requirements and true operational cash flow. It provides insight into the segment's investment in long-term infrastructure and intellectual property.

Ask your AI about Balchem's human nutrition and health — d&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude